药品名称HALFLYTELY
申请号021551产品号003
活性成分BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE市场状态停止上市
剂型或给药途径FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL规格5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2010/07/16申请机构BRAINTREE LABORATORIES INC
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
72913242022/10/22U-837PDF格式
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
NP2013/07/16
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
021551016APLetter2011/07/12下载
021551013APLabel2010/07/19下载
021551013APLetter2010/07/23下载
021551006APLabel2007/09/26下载
021551006APLetter2007/09/26下载
021551005APLetter2006/05/21下载
021551005APLabel2006/05/22下载
021551003APLetter2005/03/03下载
021551000APReview2005/12/01下载
021551000APLetter2004/05/26下载
021551000APLabel2004/05/27下载
021551000APMedication Guide2010/07/30下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
021551018AP2013/06/03Manufacturing Change or Addition
021551016AP2011/07/06Labeling Revision
021551013AP2010/07/16New Dosage Regimen
021551006AP2007/09/24New Dosage Regimen
021551005AP2006/05/18Labeling Revision
021551003AP2005/02/23Control Supplement
021551000AP2004/05/10Approval